ORBi: Browsing ORBi


	References of "Coutant, K" in Showing results 1 to 6 of 6 1 Influence of baseline patient characteristics on response to one-monthly and daily oral ibandronate therapy: 2-year findings from MOBILE Reginster, Jean-Yves ; Hawker, G.; Bolognese, M. et al in Annals of the Rheumatic Diseases (2006, June), 65(Suppl.II), 426 Detailed reference viewed: 7 (3 ULg) Once-monthly dosing of oral ibandronate is highly efficacious: 2-year results from mobile Reginster, Jean-Yves ; Stakkestad, J. A.; Lorenc, R. et al in Osteoporosis International (2006, March), 17(Suppl.1), 64-65 Detailed reference viewed: 1 (0 ULg) Monthly oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis : 1-year results from mobile Cooper, C.; Stepan, J. J.; Lorenc, R. et al in BONE (2005), 36(S2), 417 Detailed reference viewed: 2 (1 ULg) A novel bisphosphonate dosing regimen: once-monthly oral ibandronate Cooper, C.; Adami, Silvio; Stepan, J. J. et al in Annals of the Rheumatic Diseases (2004, June) Detailed reference viewed: 4 (1 ULg) Once-monthly oral ibandronate a new bisphosphonate dosing concept Reginster, Jean-Yves ; Miller, P.; Delmas, P. et al in Calcified Tissue International (2004), 74(S1), 85 Detailed reference viewed: 2 (2 ULg) Oral monthly ibandronate: rationale and clinical potential in postmenopausal osteoporosis Reginster, Jean-Yves ; McClung, M.; Coutant, K. et al in Annals of the Rheumatic Diseases (2003, June) Detailed reference viewed: 23 (11 ULg) 1